SITC 2026, 424 пациенти на имунотерапия с 4 вида метастатичен рак: при два поредни отрицателни теста Signatera 3-годишната преживяемост е 93,2% срещу 77,9% (HR 0,24).
НМ Дженомикс представлява Natera в България.
#ctDNA #онкология
НМ Дженомикс представлява Natera в България.
#ctDNA #онкология
November 8, 2026 at 9:06 AM
SITC 2026, 424 пациенти на имунотерапия с 4 вида метастатичен рак: при два поредни отрицателни теста Signatera 3-годишната преживяемост е 93,2% срещу 77,9% (HR 0,24).
НМ Дженомикс представлява Natera в България.
#ctDNA #онкология
НМ Дженомикс представлява Natera в България.
#ctDNA #онкология
Lunit Showcases Advanced AI Pathology Research on Ovarian and Bladder Cancers at SITC 2026#South_Korea#Seoul#Cancer_Research#Lunit#AI_Pathology
Lunit Showcases Advanced AI Pathology Research on Ovarian and Bladder Cancers at SITC 2026
At SITC 2026, Lunit highlights groundbreaking AI research on ovarian and bladder cancers, revealing critical insights into treatment responses and immune features.
third-news.com
November 4, 2026 at 2:58 PM
Lunit Showcases Advanced AI Pathology Research on Ovarian and Bladder Cancers at SITC 2026#South_Korea#Seoul#Cancer_Research#Lunit#AI_Pathology
I’ve wanked over all of them. Would watch SITC rock hard
November 8, 2026 at 12:35 AM
I’ve wanked over all of them. Would watch SITC rock hard
TR-GRID3.ANS, 1993-06-22 from dark domain - the artpacks.acid.org collection (CD-ROM)
November 5, 2026 at 4:45 PM
TR-GRID3.ANS, 1993-06-22 from dark domain - the artpacks.acid.org collection (CD-ROM)
Samik Upadhaya Shares Key Takeaways from SITC 2026 in Phoenix
https://www.byteseu.com/2507416/
Samik Upadhaya, Director of Scientific Affairs at Cancer Research Institute (CRI), shared on LinkedIn: “A full Friday at SITC 2026 in Phoenix, with plenty of interesting science and even better …
https://www.byteseu.com/2507416/
Samik Upadhaya, Director of Scientific Affairs at Cancer Research Institute (CRI), shared on LinkedIn: “A full Friday at SITC 2026 in Phoenix, with plenty of interesting science and even better …
Samik Upadhaya Shares Key Takeaways from SITC 2026 in Phoenix - Bytes Europe
Samik Upadhaya, Director of Scientific Affairs at Cancer Research Institute (CRI), shared on LinkedIn:
www.byteseu.com
November 8, 2026 at 7:52 PM
Samik Upadhaya Shares Key Takeaways from SITC 2026 in Phoenix
https://www.byteseu.com/2507416/
Samik Upadhaya, Director of Scientific Affairs at Cancer Research Institute (CRI), shared on LinkedIn: “A full Friday at SITC 2026 in Phoenix, with plenty of interesting science and even better …
https://www.byteseu.com/2507416/
Samik Upadhaya, Director of Scientific Affairs at Cancer Research Institute (CRI), shared on LinkedIn: “A full Friday at SITC 2026 in Phoenix, with plenty of interesting science and even better …
Innovative Findings on PB-223 ADC in Human Cancer Targeting Unveiled at SITC 2026#United_States#Phoenix#Precision_Biologics#PB-223#SITC_2026
Innovative Findings on PB-223 ADC in Human Cancer Targeting Unveiled at SITC 2026
Precision Biologics, Inc. presented encouraging findings on the PB-223 ADC targeting specific tumors at the SITC 2026, showcasing potential advancements in cancer treatment.
third-news.com
November 6, 2026 at 2:34 PM
Innovative Findings on PB-223 ADC in Human Cancer Targeting Unveiled at SITC 2026#United_States#Phoenix#Precision_Biologics#PB-223#SITC_2026
Inimmune Unveils Promising Phase 1 Results of INI-4001 Immunotherapy for Solid Tumors at SITC 2026#United_States#Cancer_Immunotherapy#Missoula#Inimmune#INI-4001
Inimmune Unveils Promising Phase 1 Results of INI-4001 Immunotherapy for Solid Tumors at SITC 2026
Inimmune Corporation has shared encouraging Phase 1 results of INI-4001, a novel immunotherapy designed for advanced solid tumors, showcasing on-target immune activation in patients at SITC 2026.
third-news.com
November 6, 2026 at 3:19 PM
Inimmune Unveils Promising Phase 1 Results of INI-4001 Immunotherapy for Solid Tumors at SITC 2026#United_States#Cancer_Immunotherapy#Missoula#Inimmune#INI-4001
Join or renew your SITC membership during the SITC Annual Meeting for your chance to win our Ultimate Conference Traveler’s Kit, valued at $400! The prize includes an Away Carry-On, AirFly Pro 2 and Pebblebee luggage tracker. Join or renew Nov. 4–8. #SITC26
https://sitc.execinc.com/edibo/Signup
https://sitc.execinc.com/edibo/Signup
November 7, 2026 at 3:45 PM
Join or renew your SITC membership during the SITC Annual Meeting for your chance to win our Ultimate Conference Traveler’s Kit, valued at $400! The prize includes an Away Carry-On, AirFly Pro 2 and Pebblebee luggage tracker. Join or renew Nov. 4–8. #SITC26
https://sitc.execinc.com/edibo/Signup
https://sitc.execinc.com/edibo/Signup
SitcomsOnline Digest: Nobody Wants This Renewed at Netflix; Grey's Anatomy Spinoff to Be Filmed in New Mexico blog.sitcomsonline.com/2026/11/sitc...
November 7, 2026 at 9:07 PM
SitcomsOnline Digest: Nobody Wants This Renewed at Netflix; Grey's Anatomy Spinoff to Be Filmed in New Mexico blog.sitcomsonline.com/2026/11/sitc...
#CADL Candel Therapeutics Presents SITC 2026 Data Highlighting Systemic Immune Activation and Survival Outcomes Across Clinical-S…
https://www.stocktitan.net/news/CADL/candel-therapeutics-presents-sitc-2026-data-highlighting-systemic-afopgensx9xc.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CADL/candel-therapeutics-presents-sitc-2026-data-highlighting-systemic-afopgensx9xc.html?utm_source=stocktitan-bluesky&utm_medium=social
Candel Therapeutics Presents SITC 2026 Data Highlighting Systemic Immune Activation and Survival Outcomes Across Clinical-Stage Portfolio
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
November 6, 2026 at 2:00 PM
#CADL Candel Therapeutics Presents SITC 2026 Data Highlighting Systemic Immune Activation and Survival Outcomes Across Clinical-S…
https://www.stocktitan.net/news/CADL/candel-therapeutics-presents-sitc-2026-data-highlighting-systemic-afopgensx9xc.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CADL/candel-therapeutics-presents-sitc-2026-data-highlighting-systemic-afopgensx9xc.html?utm_source=stocktitan-bluesky&utm_medium=social
ImmunoGenesis to Showcase IMGS-203 Progress at SITC 2026 Annual Meeting#United_States#Glioblastoma#Phoenix,_AZ#ImmunoGenesis#IMGS-203
ImmunoGenesis to Showcase IMGS-203 Progress at SITC 2026 Annual Meeting
ImmunoGenesis is set to present their innovative immunotherapy, IMGS-203, at the SITC 2026 Annual Meeting, highlighting its promise in treating glioblastoma.
third-news.com
November 4, 2026 at 6:57 PM
ImmunoGenesis to Showcase IMGS-203 Progress at SITC 2026 Annual Meeting#United_States#Glioblastoma#Phoenix,_AZ#ImmunoGenesis#IMGS-203
#IMNN IMUNON Presents New Translational Data at SITC 2026 Demonstrating How IMNN-001 Activates and Sustains Anti-Tumor T-Cell Imm…
https://www.stocktitan.net/news/IMNN/imunon-presents-new-translational-data-at-sitc-2026-demonstrating-fn5mfmqlr8kr.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IMNN/imunon-presents-new-translational-data-at-sitc-2026-demonstrating-fn5mfmqlr8kr.html?utm_source=stocktitan-bluesky&utm_medium=social
IMUNON Presents New Translational Data at SITC 2026 Demonstrating How IMNN-001 Activates and Sustains Anti-Tumor T-Cell Immunity in Advanced Ovarian Cancer
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
November 6, 2026 at 2:00 PM
#IMNN IMUNON Presents New Translational Data at SITC 2026 Demonstrating How IMNN-001 Activates and Sustains Anti-Tumor T-Cell Imm…
https://www.stocktitan.net/news/IMNN/imunon-presents-new-translational-data-at-sitc-2026-demonstrating-fn5mfmqlr8kr.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IMNN/imunon-presents-new-translational-data-at-sitc-2026-demonstrating-fn5mfmqlr8kr.html?utm_source=stocktitan-bluesky&utm_medium=social
I looked at the business behind $SITC (SITE Centers Corp.) for you. Based on financial data and reported results.
At what market price would buying or selling $SITC make sense to you?
#SITC
At what market price would buying or selling $SITC make sense to you?
#SITC
November 3, 2026 at 6:24 PM
I looked at the business behind $SITC (SITE Centers Corp.) for you. Based on financial data and reported results.
At what market price would buying or selling $SITC make sense to you?
#SITC
At what market price would buying or selling $SITC make sense to you?
#SITC
OncoC4 Showcases Promising Phase 1/2 Results for Cesalatamig Monotherapy at SITC 2026#USA#Phoenix#NSCLC#OncoC4#Cesalatamig
OncoC4 Showcases Promising Phase 1/2 Results for Cesalatamig Monotherapy at SITC 2026
OncoC4 Inc. reveals noteworthy Phase 1/2 data for cesalatamig monotherapy in treating previously treated non-small cell lung cancer, highlighting its potential efficacy.
third-news.com
November 6, 2026 at 2:57 PM
OncoC4 Showcases Promising Phase 1/2 Results for Cesalatamig Monotherapy at SITC 2026#USA#Phoenix#NSCLC#OncoC4#Cesalatamig
Join or renew your SITC membership during the SITC Annual Meeting for your chance to win our Ultimate Conference Traveler’s Kit, valued at $400! The prize includes an Away Carry-On, AirFly Pro 2 and Pebblebee luggage tracker. Join or renew Nov. 4–8. #SITC26
https://sitc.execinc.com/edibo/Signup
https://sitc.execinc.com/edibo/Signup
November 5, 2026 at 8:15 PM
Join or renew your SITC membership during the SITC Annual Meeting for your chance to win our Ultimate Conference Traveler’s Kit, valued at $400! The prize includes an Away Carry-On, AirFly Pro 2 and Pebblebee luggage tracker. Join or renew Nov. 4–8. #SITC26
https://sitc.execinc.com/edibo/Signup
https://sitc.execinc.com/edibo/Signup
Did Ultron Kill F.R.I.D.A.Y. in ‘VisionQuest’? The Shocking Betrayal Explained
Did Ultron Kill F.R.I.D.A.Y. in ‘VisionQuest’? The Shocking Betrayal Explained
Marvel Studios has spent recent years reshaping the Marvel Cinematic Universe by steering prestige television toward deeply introspective character studies. After exploring grief through classic sitc…
www.comicbasics.com
November 4, 2026 at 1:21 PM
Did Ultron Kill F.R.I.D.A.Y. in ‘VisionQuest’? The Shocking Betrayal Explained
$CMPX #Biotech #SITC2026 — Compass presented SITC data on the CTX-10726 mechanism. Mechanism data support the program, not clinical efficacy.
https://www.merlintrader.com/compass-therapeutics-cmpx-stock-hub/
https://www.merlintrader.com/compass-therapeutics-cmpx-stock-hub/
November 6, 2026 at 8:52 PM
$CMPX #Biotech #SITC2026 — Compass presented SITC data on the CTX-10726 mechanism. Mechanism data support the program, not clinical efficacy.
https://www.merlintrader.com/compass-therapeutics-cmpx-stock-hub/
https://www.merlintrader.com/compass-therapeutics-cmpx-stock-hub/
#$IMRX: SITC 2026 data: atebimetinib + anti-PD-1 gave complete regression in 50% of mice in a RAS-mutant colorectal model. Phase 2 1L NSCLC dosing expected by year-end. Not investment advice.
www.merlintrader.com/immuneering-...
www.merlintrader.com/immuneering-...
November 8, 2026 at 6:06 AM
#$IMRX: SITC 2026 data: atebimetinib + anti-PD-1 gave complete regression in 50% of mice in a RAS-mutant colorectal model. Phase 2 1L NSCLC dosing expected by year-end. Not investment advice.
www.merlintrader.com/immuneering-...
www.merlintrader.com/immuneering-...
#PHIO Phio Pharmaceuticals Announces Invitation for Oral Presentation at 41st Annual SITC Meeting (Society for Immunotherapy of…
https://www.stocktitan.net/news/PHIO/phio-pharmaceuticals-announces-invitation-for-oral-presentation-at-n6lcqinag2sd.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/PHIO/phio-pharmaceuticals-announces-invitation-for-oral-presentation-at-n6lcqinag2sd.html?utm_source=stocktitan-bluesky&utm_medium=social
Phio Pharmaceuticals Announces Invitation for Oral Presentation at 41st Annual SITC Meeting (Society for Immunotherapy of Cancer)
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
November 6, 2026 at 2:06 PM
#PHIO Phio Pharmaceuticals Announces Invitation for Oral Presentation at 41st Annual SITC Meeting (Society for Immunotherapy of…
https://www.stocktitan.net/news/PHIO/phio-pharmaceuticals-announces-invitation-for-oral-presentation-at-n6lcqinag2sd.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/PHIO/phio-pharmaceuticals-announces-invitation-for-oral-presentation-at-n6lcqinag2sd.html?utm_source=stocktitan-bluesky&utm_medium=social
So great to reconnect with longtime friends at #SITC2026! ❤️ Four former chairs of the SITC Early Career Scientists Committee, and friendships that have lasted well beyond our ECS days! @sitcancer.bsky.social
November 6, 2026 at 4:18 PM
So great to reconnect with longtime friends at #SITC2026! ❤️ Four former chairs of the SITC Early Career Scientists Committee, and friendships that have lasted well beyond our ECS days! @sitcancer.bsky.social
$CADL #Clinical #Biotech — Candel Therapeutics presents SITC 2026 data on systemic immune activation and survival outcomes
https://justcharts.merlintrader.com/?utm_source=bluesky&utm_medium=social&utm_campaign=jc20261107&utm_content=CADL#CADL
Visit Justcharts for bull/bear scenarios.
https://justcharts.merlintrader.com/?utm_source=bluesky&utm_medium=social&utm_campaign=jc20261107&utm_content=CADL#CADL
Visit Justcharts for bull/bear scenarios.
November 7, 2026 at 6:19 AM
$CADL #Clinical #Biotech — Candel Therapeutics presents SITC 2026 data on systemic immune activation and survival outcomes
https://justcharts.merlintrader.com/?utm_source=bluesky&utm_medium=social&utm_campaign=jc20261107&utm_content=CADL#CADL
Visit Justcharts for bull/bear scenarios.
https://justcharts.merlintrader.com/?utm_source=bluesky&utm_medium=social&utm_campaign=jc20261107&utm_content=CADL#CADL
Visit Justcharts for bull/bear scenarios.
#$AGEN: over half of refractory MSS colorectal cancer patients reached long-term survival on BOT+BAL, per SITC 2026 data (Nov 6). ROBBIN Phase 3 dosing expected Q1 2027. Not investment advice.
www.merlintrader.com/agenus-inc-s...
www.merlintrader.com/agenus-inc-s...
November 8, 2026 at 5:52 AM
#$AGEN: over half of refractory MSS colorectal cancer patients reached long-term survival on BOT+BAL, per SITC 2026 data (Nov 6). ROBBIN Phase 3 dosing expected Q1 2027. Not investment advice.
www.merlintrader.com/agenus-inc-s...
www.merlintrader.com/agenus-inc-s...
$CMPX #Preclinical #Biotech — Compass Therapeutics Presents Novel Mechanism of Action Data for CTX-10726 at SITC 2026
https://justcharts.merlintrader.com/?utm_source=bluesky&utm_medium=social&utm_campaign=jc20261107&utm_content=CMPX#CMPX
Visit Justcharts for bull/bear scenarios.
https://justcharts.merlintrader.com/?utm_source=bluesky&utm_medium=social&utm_campaign=jc20261107&utm_content=CMPX#CMPX
Visit Justcharts for bull/bear scenarios.
November 7, 2026 at 6:14 AM
$CMPX #Preclinical #Biotech — Compass Therapeutics Presents Novel Mechanism of Action Data for CTX-10726 at SITC 2026
https://justcharts.merlintrader.com/?utm_source=bluesky&utm_medium=social&utm_campaign=jc20261107&utm_content=CMPX#CMPX
Visit Justcharts for bull/bear scenarios.
https://justcharts.merlintrader.com/?utm_source=bluesky&utm_medium=social&utm_campaign=jc20261107&utm_content=CMPX#CMPX
Visit Justcharts for bull/bear scenarios.